Source: FirstWord Pharma

Catamaran Bio: Catamaran Bio to Present Preclinical Data at ASGCT Annual Meeting to Support CAR-NK Approach for Solid Tumors

- Two posters describe features of Catamaran's CAR-NK platform designed to overcome the immunosuppressive effects of the solid tumor microenvironment- CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ca...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Alvin Shih's photo - President & CEO of Catamaran Bio

President & CEO

Alvin Shih

CEO Approval Rating

90/100

Read more